Greenwich LifeSciences is a biopharmaceutical company dedicated to the development of novel immunotherapy products for the treatment of cancer. With a focus on breast cancer, the company aims to revolutionize cancer treatment through its innovative approaches to harnessing the power of the immune system. Through cutting-edge research and a commitment to improving patient outcomes, Greenwich LifeSciences is at the forefront of advancing cancer immunotherapy to address unmet medical needs in oncology.

Refer new talent to Greenwich Lifesciences